May KORUS FTA give benefis to pharmaceutical industry?

Published: 2011-11-01 06:59:00

Updated: 2011-11-01 06:59:00

The ruling Grand National Party (GNP) is set to ratify the long-pending Korea-U.S. free trade agreement (KORUS FTA) soon as the ational Assembly is locked in an impasse with the ruling and the opposition parties showing no signs of backing down from their position on the KORUS FTA.

In the mids...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK